financetom
Business
financetom
/
Business
/
--Manhattan Bridge Capital Keeps Quarterly Dividend at $0.115 a Share, Payable Oct. 15 to Holders of Record Oct. 8
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Manhattan Bridge Capital Keeps Quarterly Dividend at $0.115 a Share, Payable Oct. 15 to Holders of Record Oct. 8
Jul 28, 2025 11:04 AM

01:51 PM EDT, 07/28/2025 (MT Newswires) --

Price: 5.40, Change: -0.03, Percent Change: -0.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biden-Trump debate draws 48 million TV viewers
Biden-Trump debate draws 48 million TV viewers
Jun 28, 2024
NEW YORK, June 28 (Reuters) - Roughly 48 million TV viewers tuned in to watch Thursday's U.S. presidential debate between Democratic President Joe Biden and Republican rival Donald Trump, according to preliminary Nielsen data. The numbers suggest the final audience will be about one-third lower than the 73 million people who watched the candidates' first face-off in 2020. The relatively...
Aptevo Shares Decline After Pricing of $2.8 Million Stock Offering
Aptevo Shares Decline After Pricing of $2.8 Million Stock Offering
Jun 28, 2024
01:48 PM EDT, 06/28/2024 (MT Newswires) -- Aptevo Therapeutics ( APVO ) was down nearly 38% in recent Friday trading after it priced a share offering to raise about $2.8 million. The company said it entered agreements with certain healthcare-focused and institutional investors to buy more than 5.3 million shares at $0.515 each, bundled with warrants to buy up to...
Why Are Carisma Therapeutics Shares Surging Friday?
Why Are Carisma Therapeutics Shares Surging Friday?
Jun 28, 2024
Carisma Therapeutics Inc. ( CARM ) shares are trading higher on Friday following the company’s announcement of a significant development in its collaboration with Moderna. What To Know: Carisma has nominated its first in vivo CAR-M development candidate targeting Glypican-3 (GPC3) for the treatment of solid tumors, including hepatocellular carcinoma (HCC). This milestone has triggered a $2 million payment to...
US urges dismissal of lawsuit seeking menthol cigarette ban
US urges dismissal of lawsuit seeking menthol cigarette ban
Jun 28, 2024
June 28 (Reuters) - The Biden administration asked a federal judge to dismiss a lawsuit by anti-smoking groups demanding that it end nearly a year of delay and ban menthol cigarettes, which are used disproportionately by Blacks and younger people. In a Thursday night court filing, the Food and Drug Administration said the delay was not unreasonable because it had...
Copyright 2023-2026 - www.financetom.com All Rights Reserved